Top

Helix BioPharma Corp. Common

TSX Exchange | Aug 8, 2020, 1:01 PM EDT | Real-time price

HBP $ 0.55 RT
CHANGE
0.01 (1.8519%)
VOLUME
12,437
Day Low: 0.53
Day High: 0.55
Detailed Quote
Open: 0.54
High: 0.55
Beta: -0.1487
Listed Shares Out.1: 132,933,017
Total Shares (All Classes)2: 132,933,017
Prev. Close: 0.54
Low: 0.53
VWAP: 0.5488
Market Cap1: 73,113,159
Market Cap (All Classes)2*: 73,113,159
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
EPS: -0.08
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: 13.75
Exchange: TSX

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.

Description

Helix BioPharma Corp is a Canada-based clinical-stage biopharmaceutical company focused on cancer drug development. It develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. The company has Tumor Defense Breakers (L-DOS47), and Tumor Attackers (CAR-T) product candidates in the pipeline. More

News Headlines for Helix BioPharma Corp. Common
Research
News Headlines for Helix BioPharma Corp. Common
Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.